GlassScriptPhysician profile
Arie Gluzman
NPI 1528179017
$1,781.68
in general payments reported to CMS, 2019-2025
21 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $43.39 · 2021: $111 · 2022: $548 · 2023: $319 · 2024: $229 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.25 | 2021-2025 | |
| Medtronic, INC. | $162.03 | 2022 | |
| Spr Therapeutics, INC | $110.35 | 2022-2023 | Sprint Pns System |
| Curonix LLC | $104.62 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $102.14 | 2019-2023 | Xtampza |
| Allergan, INC. | $78.58 | 2019-2021 | |
| Pfizer INC. | $75.75 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $73.34 | 2019 | |
| Stimwave Technologies Incorporated | $64.47 | 2019-2022 | |
| Bioventus LLC | $51.63 | 2019-2025 | Xcell |
| Ossur Americas, INC. | $46.45 | 2025 | Unloader One X |
| Electronic Waveform Lab, INC. | $41.81 | 2019 | |
| Lilly USA, LLC | $36.15 | 2019-2021 | |
| Amgen INC. | $25.97 | 2019 | |
| Nevro Corp. | $23.55 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Grt US Holding, INC. | $18.81 | 2022 | |
| Valinor Pharma, LLC | $18.04 | 2024 | Movantik |
| Scilex Pharmaceuticals INC. | $17.74 | 2019 | |
| Forte Bio-Pharma LLC | $17.57 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arie Gluzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.